Edition:
United States

Quidel Corp (QDEL.O)

QDEL.O on Nasdaq

22.09USD
1:32pm EST
Change (% chg)

$0.07 (+0.32%)
Prev Close
$22.02
Open
$22.06
Day's High
$22.15
Day's Low
$21.69
Volume
10,808
Avg. Vol
112,364
52-wk High
$23.94
52-wk Low
$13.21

Latest Key Developments (Source: Significant Developments)

Quidel receives FDA clearance for Solana Influenza A+B Assay
Tuesday, 27 Sep 2016 01:14pm EDT 

Quidel Corp : Quidel receives FDA clearance for its Solana(R) Influenza A+B assay in time for the upcoming 2016-2017 flu season .Received 510(k) clearance from United States Food and Drug Administration (FDA) to market its Solana Influenza A+B assay.  Full Article

Quidel gets FDA clearance for Solana Trichomonas assay
Wednesday, 17 Aug 2016 02:00pm EDT 

Quidel Corp : Quidel receives FDA clearance for its Solana Trichomonas assay for diagnosis of trichomoniasis .Has received clearance from United States Food and Drug Administration to market its Solana Trichomonas assay.  Full Article

Quidel Q2 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S
Wednesday, 27 Jul 2016 04:10pm EDT 

Quidel Corp : Quidel reports second quarter 2016 financial results . Q2 Non-GAAP loss per share $0.11 . Q2 GAAP loss per share $0.24 . Q2 revenue $39.1 million versus I/B/E/S view $38 million .Q2 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S.  Full Article

Quidel Corp receives FDA clearance for amplivue trichomonas assay
Tuesday, 17 Mar 2015 01:15pm EDT 

Quidel Corp:Receives clearance from United States Food and Drug Administration (FDA) to market its amplivue trichomonas assay for detection of nucleic acids isolated from clinician-collected vaginal swab specimens obtained from symptomatic or asymptomatic female patients.Says this molecular assay aids in diagnosis of trichomoniasis, a sexually transmitted disease attributable to infection by trichomonas vaginalis parasite.  Full Article

Quidel Corporation receives simultaneous FDA clearance
Wednesday, 17 Dec 2014 06:45pm EST 

Quidel Corporation:Says that it has received marketing clearance and CLIA waiver by the United States Food and Drug Administration (FDA) for its Sofia Strep A+ Fluorescent Immunoassay (FIA) for the rapid detection of infections by Group A Streptococcus bacteria.  Full Article

BRIEF-Quidel receives FDA clearance for Solana(r) molecular assay

* Quidel receives FDA clearance for its new Solana(r) molecular assay for the detection of herpes simplex virus 1+2 and varicella zoster virus Source text for Eikon: Further company coverage: